VANGUARD GROUP INC - C4 THERAPEUTICS INC ownership

C4 THERAPEUTICS INC's ticker is CCCC and the CUSIP is 12529R107. A total of 123 filers reported holding C4 THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.75 and the average weighting 0.2%.

Quarter-by-quarter ownership
VANGUARD GROUP INC ownership history of C4 THERAPEUTICS INC
ValueSharesWeighting
Q2 2024$16,431,949
-31.1%
3,556,699
+21.8%
0.00%
Q1 2024$23,856,629
+111.2%
2,920,028
+46.0%
0.00%
Q4 2023$11,296,616
+215.5%
1,999,401
+3.9%
0.00%
Q3 2023$3,580,232
-31.5%
1,924,856
+1.3%
0.00%
Q2 2023$5,225,979
-21.2%
1,900,356
-10.0%
0.00%
Q1 2023$6,633,331
-45.6%
2,112,526
+2.3%
0.00%
Q4 2022$12,182,998
-31.2%
2,064,915
+2.2%
0.00%
-100.0%
Q3 2022$17,711,000
+19.8%
2,019,654
+3.0%
0.00%
Q2 2022$14,783,000
-69.9%
1,960,713
-3.0%
0.00%
-100.0%
Q1 2022$49,057,000
-24.4%
2,022,142
+0.3%
0.00%0.0%
Q4 2021$64,929,000
-25.0%
2,016,459
+4.0%
0.00%
-50.0%
Q3 2021$86,616,000
+62.7%
1,938,575
+37.8%
0.00%
+100.0%
Q2 2021$53,234,000
+270.9%
1,406,840
+262.6%
0.00%
Q1 2021$14,351,000
-4.2%
387,958
-14.2%
0.00%
Q4 2020$14,980,000452,1670.00%
Other shareholders
C4 THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Lynx1 Capital Management LP 6,880,527$31,788,03511.47%
Soleus Capital Management, L.P. 4,051,996$18,720,2221.65%
SILVERARC CAPITAL MANAGEMENT, LLC 1,442,841$6,665,9251.57%
COMMODORE CAPITAL LP 3,410,384$15,755,9741.08%
TCG Crossover Management, LLC 1,276,574$5,897,7720.62%
Bain Capital Life Sciences Investors, LLC 1,111,910$5,137,0240.56%
RA Capital Management 4,878,000$22,536,3600.30%
Atom Investors LP 332,620$1,536,7040.15%
Orbimed Advisors 1,513,058$6,990,3280.14%
WASATCH ADVISORS LP 4,847,150$22,393,8330.12%
View complete list of C4 THERAPEUTICS INC shareholders